Centene Stock Approaches 52-Week High on Faster-Than-Expected Earnings Recovery

What happened

Centene reported third-quarter adjusted earnings of 58 cents, beating expectations, with sales of $50.647 billion exceeding the $47.114 billion consensus. Its health benefits ratio was 92.7%, and total membership fell to 25.698 million.

Confirmed

Global impact / market context

Higher sales and a better health benefits ratio, which means the share of premiums paid toward medical care, suggest Centene keeps more of each premium dollar. That supports profit recovery even as membership shrinks, though fewer members could limit future revenue growth.

Analyst inference

Centene's stock is nearing a 52-week high as investors weigh faster earnings recovery against falling membership. Medicaid and Marketplace enrollment declines, plus expected state Medicaid cuts before 2027, create uncertainty about how long the profit improvement can continue.

Analyst inference

What to watch

1. Centene expects some states to keep trimming Medicaid rolls before OB3 implementation in 2027, and it holds a full-year membership decline view of 8% to 9%. Confirmed
2. Centene is forecasting Medicare Advantage break-even in 2026, a year earlier than its prior multi-year plan, so watch whether that target is met. Proposed
3. Watch the health benefits ratio, which means medical costs as a share of premiums; if it rises above the stated full-year Medicaid aim, profit recovery could slow. Analyst inference

Evidence

• Original source link unavailable